Literature DB >> 28325318

Preparation and characterization of amine functional nano-hydroxyapatite/chitosan bionanocomposite for bone tissue engineering applications.

Besir Hakan Atak1, Berna Buyuk2, Merve Huysal3, Sevim Isik4, Mehmet Senel5, Wolfgang Metzger6, Guven Cetin7.   

Abstract

In this study, three different types of scaffolds including a uniquely modified composite scaffold - namely chitosan (CTS), nano-hydroxyapatite/chitosan composite (CTS+nHAP), and amine group (NH2) modified nano-hydroxyapatite/chitosan composite (CTS+nHAP-NH2) scaffolds - were synthesized for bone tissue engineering (BTE) purposes. As results of the study, it was found that all scaffold types were biodegradable with CTS and CTS+nHAP scaffolds losing up to 15% of their initial weight, while the CTS+nHAP-NH2 scaffold showing 10% of weight loss after six weeks of lysozyme treatment. In addition, all three types of scaffolds were shown to be biocompatible, and amongst them CTS+nHAP-NH2 scaffolds supported the most cell proliferation in WST-1 assay and expressed the least and acceptable level of cytotoxicity in lactate dehydrogenase (LDH) test for human bone mesenchymal stem cells (hBM-MSCs). Finally, during osteoinductivity assessment, CTS+nHAP-NH2 nearly tripled initial alkaline phosphatase (ALP) activity when whereas both CTS and CTS+nHAP scaffolds only doubled. These results indicate that all synthesized scaffold types under investigation have certain potential to be used in bone tissue engineering approaches with CTS+nHAP-NH2 scaffold being the most promising and applicable one. In the future, we plan to intensify our studies on osteogenic differentiation on our scaffolds on a detailed molecular level and to include in vivo studies for pre-clinical purposes.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chitosan; Human mesenchymal stem cells; Hydroxyapatite; Osteogenic differentiation; Scaffold

Mesh:

Substances:

Year:  2017        PMID: 28325318     DOI: 10.1016/j.carbpol.2017.01.100

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  7 in total

1.  In vitro and in vivo evaluation of rotary-jet-spun poly(ɛ-caprolactone) with high loading of nano-hydroxyapatite.

Authors:  Telmo M Andrade; Daphne C R Mello; Conceição M V Elias; Julia M A Abdala; Edmundo Silva; Luana M R Vasconcellos; Carla R Tim; Fernanda R Marciano; Anderson O Lobo
Journal:  J Mater Sci Mater Med       Date:  2019-01-28       Impact factor: 3.896

Review 2.  Recent trends in the application of widely used natural and synthetic polymer nanocomposites in bone tissue regeneration.

Authors:  Angshuman Bharadwaz; Ambalangodage C Jayasuriya
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-01-29       Impact factor: 7.328

3.  In vitro studies on gelatin/hydroxyapatite composite modified with osteoblast for bone bioengineering.

Authors:  Namrata Yadav; Pradeep Srivastava
Journal:  Heliyon       Date:  2019-05-09

4.  Presentation of Antibacterial and Therapeutic Anti-inflammatory Potentials to Hydroxyapatite via Biomimetic With Azadirachta indica: An in vitro Anti-inflammatory Assessment in Contradiction of LPS-Induced Stress in RAW 264.7 Cells.

Authors:  Anusuya Nagaraj; Suja Samiappan
Journal:  Front Microbiol       Date:  2019-08-07       Impact factor: 5.640

5.  Synthesis and Evaluation of BMMSC-seeded BMP-6/nHAG/GMS Scaffolds for Bone Regeneration.

Authors:  Xuewen Li; Ran Zhang; Xuexin Tan; Bo Li; Yao Liu; Xukai Wang
Journal:  Int J Med Sci       Date:  2019-06-10       Impact factor: 3.738

6.  3D gel-printed porous magnesium scaffold coated with dibasic calcium phosphate dihydrate for bone repair in vivo.

Authors:  Yuxuan Zhang; Tao Lin; Haoye Meng; Xueting Wang; Hong Peng; Guangbo Liu; Shuai Wei; Qiang Lu; Yu Wang; Aiyuan Wang; Wenjing Xu; Huiping Shao; Jiang Peng
Journal:  J Orthop Translat       Date:  2022-02-03       Impact factor: 5.191

Review 7.  Hydroxyapatite from Fish for Bone Tissue Engineering: A Promising Approach.

Authors:  Renata Neves Granito; Ana Claudia Muniz Renno; Hirochi Yamamura; Matheus Cruz de Almeida; Pedro Luiz Menin Ruiz; Daniel Araki Ribeiro
Journal:  Int J Mol Cell Med       Date:  2018-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.